AU - Padhy, Srikant AU - Kumar, Vinod TI - Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy PT - CASE DP - 2018 Oct 1 TA - Indian Journal of Ophthalmology PG - 1494-1495 VI - 66 IP - 10 4099- https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2018;volume=66;issue=10;spage=1494;epage=1495;aulast=Padhy;type=0 4100- https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2018;volume=66;issue=10;spage=1494;epage=1495;aulast=Padhy AB - Hypertensive retinopathy is seen frequently in patients with systemic hypertension and is usually asymptomatic. An acute rise in blood pressure may lead to exudative changes in the form of macular edema, hemorrhages, and serous macular detachment that can lead to visual decline. The authors report prompt resolution of exudative changes in a case of hypertensive retinopathy following intravitreal bevacizumab.